Locally advanced squamous cell carcinoma of the head and neck: CT texture and histogram analysis allow independent prediction of overall survival in patients treated with induction chemotherapy.

PURPOSE To determine if computed tomographic (CT) texture and histogram analysis measurements of the primary mass are independently associated with overall survival in patients with locally advanced squamous cell carcinoma of the head and neck who were previously treated with cisplatin, 5-fluorouracil, and docetaxel (TPF) induction chemotherapy. MATERIALS AND METHODS This institutional review board-approved retrospective study included 72 patients with locally advanced squamous cell carcinoma of the head and neck who were treated with induction TPF chemotherapy in 2004-2010. CT texture and histogram analysis of the primary mass on the pretherapy CT images were performed by using TexRAD software before and after application of spatial filters at different anatomic scales ranging from fine detail to coarse features. Cox proportional hazards models were used to examine the association between overall survival and the baseline CT imaging measurements and clinical variables. RESULTS Primary mass entropy and skewness measurements with multiple spatial filters were associated with overall survival. Multivariate Cox regression analysis incorporating clinical and imaging variables indicated that primary mass size (hazard ratio [HR], 1.58 for each 1-cm increase; P = .018), N stage (HR, 8.77 for N3 vs N0 or N1; P = .002; HR, 4.99 for N3 vs N2; P = .001), and primary mass entropy (HR, 2.10 for each 0.5-unit increase; P = .036) and skewness (HR, 3.67 for each 1.0-unit increase; P = .009) measurements with the 1.0 spatial filter were independently associated with overall survival. CONCLUSION Independent of tumor size, N stage, and other clinical variables, primary mass CT texture and histogram analysis parameters are associated with overall survival in patients with locally advanced squamous cell carcinoma of the head and neck who were treated with induction TPF. Online supplemental material is available for this article.

[1]  K. Miles,et al.  Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival , 2012, European Radiology.

[2]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.

[3]  P. Parsons,et al.  Novel markers for poor prognosis in head and neck cancer , 2005, International journal of cancer.

[4]  E. Munck‐Wikland,et al.  Human papillomavirus and survival in patients with base of tongue cancer , 2011, International Journal of Cancer.

[5]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[6]  R. Tishler,et al.  Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment. , 2003, The Oncologist.

[7]  V. Budach.  TPF sequential therapy: when and for whom? , 2010, The Oncologist.

[8]  David L Rimm,et al.  Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[9]  W. Gstoettner,et al.  Adjuvant docetaxel, cisplatin and 5-fluorouracil (TPF) in locally advanced squamous cell carcinoma of the head and neck. , 2006, Anticancer Research.

[10]  J. Stockman.  Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer , 2012 .

[11]  B. Teicher.  Hypoxia and drug resistance , 1994, Cancer and Metastasis Reviews.

[12]  K. Haustermans,et al.  Hypoxia in head and neck cancer: How much, how important? , 2005, Head & neck.

[13]  D. Cox,et al.  A General Definition of Residuals , 1968 .

[14]  T. Lumley,et al.  Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.

[15]  Balaji Ganeshan,et al.  Colorectal cancer: texture analysis of portal phase hepatic CT images as a potential marker of survival. , 2009, Radiology.

[16]  K. Hörmann,et al.  Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck. , 2010, Oncology Report.

[17]  R. Arceci.  Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing , 2012 .

[18]  M. Kies,et al.  Docetaxel in the treatment of squamous cell carcinoma of the head and neck , 2008, Therapeutics and clinical risk management.

[19]  V. Goh,et al.  Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. , 2011, Radiology.

[20]  Omar Sultan Al-Kadi,et al.  Texture analysis of CT images in the characterization of oral cancers involving buccal mucosa. , 2012, Dento maxillo facial radiology.

[21]  M. Tan,et al.  beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  M. Rasse,et al.  High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. , 2007, Oral oncology.

[23]  E. Douzinas,et al.  Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up. , 2006, Oral oncology.

[24]  V. Goh,et al.  Non-small cell lung cancer: histopathologic correlates for texture parameters at CT. , 2013, Radiology.

[25]  K. Miles,et al.  Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. , 2012, Clinical radiology.